HCM is a relatively common genetic cardiomyopathy that can be a challenge to diagnose, with about one in three patients misdiagnosed as having another cardiomyopathy. Genetic testing identifies a ...
A study has found that aficamten is associated with improvements across a range of clinical outcomes in patients with obstructive hypertrophic cardiomyopathy.
American Heart Association Expands HCM Awareness Initiative at HBCUs Summary: AHA offers free HCM screenings to Claflin University student-athletes, promoting cardiovascular health and early detection ...
. In India, one in five patients suffering sudden cardiac arrest is less than 40 years of age.(Pexels/Towfiqu Barbhuiya) A physically fit, mentally agile, 42-year-old army officer goes out for a ...
Some results have been hidden because they may be inaccessible to you